Charles Windon, MD

Assistant Professor
+1 415 353-2057
Fields of Interest
Biomarkers

Dr. Charles Windon is an assistant professor of clinical neurology at the UCSF Edward and Pearl Fein Memory and Aging Center, where he specializes in the care of patients with neurodegenerative diseases and cognitive disorders. In addition to his clinical work, Dr. Windon is deeply committed to community outreach, with a particular focus on addressing health disparities in dementia care. He is passionate about improving access to care, especially in medically, economically, or educationally disadvantaged populations in the San Francisco Bay Area and beyond.

Dr. Windon earned his bachelor’s degree in molecular biology from Princeton University and his medical degree from Rutgers-Robert Wood Johnson Medical School in New Jersey. He completed his internship at Drexel University Hahnemann Hospital, followed by residency training in neurology at the University of California, Los Angeles. He then pursued fellowship training in behavioral neurology at the UCSF Fein Memory and Aging Center.

As a researcher, Dr. Windon seeks to advance understanding of neurodegenerative diseases, particularly Alzheimer’s disease, by studying biomarkers and developing strategies for earlier diagnosis. He is particularly interested in identifying and addressing disparities in dementia outcomes, with the goal of eliminating them through innovative approaches and collaborative efforts, thereby ensuring equitable care and treatment opportunities for all patients.

Dr. Windon is also actively involved in community outreach programs and volunteer clinical care, working to educate and support aging populations disproportionately affected by dementia.

Outside of medicine, Dr. Windon is an avid golfer and has enjoyed the sport for over 20 years.

Publications

Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts.

Lagarde J, Maiti P, Schonhaut DR, Blazhenets G, Zhang J, Eloyan A, Thangarajah M, Taurone A, Allen IE, Soleimani-Meigooni DN, Zeltzer E, Windon C, Abu Raya M, Vrillon A, Smith K, Shankar R, Amuiri A, Rocha S, Hammers DB, Dage JL, Nudelman KN, Kirby K, Aisen P, Koeppe R, Landau SM, Carrillo MC, Touroutoglou A, Brickhouse M, Vemuri P, Beckett L, Raman R, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu JC, Mendez MF, Womack K, Musiek E, Onyike CU, Riddle M, Grant IM, Rogalski E, Johnson ECB, Salloway S, Sha S, Turner RS, Wingo TS, Wolk DA, Dickerson BC, Apostolova LG, La Joie R, Rabinovici GD, LEADS Consortium for the Alzheimer's Disease Neuroimaging Initiative

Annals of neurology

Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS).

Cho H, Mundada NS, Apostolova LG, Carrillo MC, Shankar R, Amuiri AN, Zeltzer E, Windon CC, Soleimani-Meigooni DN, Tanner JA, Heath CL, Lesman-Segev OH, Aisen P, Eloyan A, Lee HS, Hammers DB, Kirby K, Dage JL, Fagan A, Foroud T, Grinberg LT, Jack CR, Kramer J, Kukull WA, Murray ME, Nudelman K, Toga A, Vemuri P, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Riddle M, Rogalski EJ, Salloway S, Sha S, Turner RS, Wingo TS, Wolk DA, Koeppe R, Iaccarino L, Dickerson BC, La Joie R, Rabinovici GD, LEADS Consortium

Alzheimer's & dementia : the journal of the Alzheimer's Association